|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> Vaniprevir>> 市场分析报告 |
Vaniprevir市场分析报告 |
|
KOL Insight: Hepatitis C: the Race for the First Interferon-free Regimen Analyzing the Hepatitis C Market Landscape After more than a decade of limited treatment options, the hepatitis C (HCV) market is on the cusp of a treatment revolution. In 2011, protease inhibitors-Incivek (telaprevir; Vertex) and Victrelis (boceprevir; ... Therapy Trends Consensus Outlook: Hepatitis C The worldwide hepatitis C (HCV) market is forecast to grow from $3.8 billion in 2011 to $14.5 billion in 2020. The catalysts for this growth include a boost in diagnosis rates following an increase in screening, and the introduction more effective and ... Hepatitis C: Game changing regimens to revolutionise treatment landscape - Consensus Outlook The worldwide hepatitis C (HCV) market is forecast to grow from $4.7 billion in 2012 to $17.7 billion in 2017. The catalysts for this growth include a boost in diagnosis rates following an increase in screening, and the introduction more effective and ... Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global Market for Hepatitis C drugs has grown with a phenomenal rate of more than US$ 13 Billion, in the year 2014 compared to 2013. In the last two years a couple of new drugs have been introduced in the market which has become a huge success and they have ... Worldwide - Hepatitis C Drugs Market and Pipeline Drugs Analysis to 2019 ... Franchise (AbbVie) 3. PEG-Interferon Lambda 4. Vaniprevir 5. MK-8742 + MK-5172 33 6. Mericitabine or RG7128 7. Sunvepra ... Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016 Hepatitis C virus drug market is experiencing a dramatic near-term growth, by crossing US$ 6 Billion in 2011 and is expected to be more than double of its current figure by 2015. This robust growth will be driven primarily by the launch of novel premium- ... |